Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Working Capital Changes: 2020-2024

Historic Other Working Capital Changes for Immuneering (IMRX) over the last 5 years, with Dec 2024 value amounting to -$300,102.

  • Immuneering's Other Working Capital Changes fell 1761.98% to -$1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$300,102, marking a year-over-year increase of 20.76%. This contributed to the annual value of -$300,102 for FY2024, which is 20.76% up from last year.
  • Latest data reveals that Immuneering reported Other Working Capital Changes of -$300,102 as of FY2024, which was up 20.76% from -$378,723 recorded in FY2023.
  • In the past 5 years, Immuneering's Other Working Capital Changes registered a high of $2.4 million during FY2021, and its lowest value of -$378,723 during FY2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$300,102 (2024), whereas its average is -$106,208.
  • In the last 5 years, Immuneering's Other Working Capital Changes soared by 3,354.24% in 2021 and then tumbled by 205.14% in 2023.
  • Yearly analysis of 5 years shows Immuneering's Other Working Capital Changes stood at $69,740 in 2020, then spiked by 3,354.24% to $2.4 million in 2021, then tumbled by 85.05% to $360,200 in 2022, then tumbled by 205.14% to -$378,723 in 2023, then increased by 20.76% to -$300,102 in 2024.